AstraZeneca, Circassia Partner on COPD Medications Tudorza and Duaklir for U.S. Market
COPD, News
AstraZeneca and Circassia Pharmaceuticals will joint develop and market Tudorza and Duaklir — inhaled drugs to treat chronic obstructive pulmonary disease (COPD) — in the United States. Tudorza received Food and Drug ... Read more